Maternal & Child Health Research Institute (MCHRI)
Showing 201-300 of 1,214 Results
-
Todd Coleman
Associate Professor of Bioengineering and, by courtesy, of Electrical Engineering
BioTodd P. Coleman is an Associate Professor in the Department of Bioengineering, and by courtesy, Electrical Engineering at Stanford University. He received B.S. degrees in electrical engineering (summa cum laude), as well as computer engineering (summa cum laude) from the University of Michigan (Go Blue). He received M.S. and Ph.D. degrees from MIT in electrical engineering and computer science. He did postdoctoral studies at MIT and Mass General Hospital in quantitative neuroscience. He previously was a faculty member in the Departments of Electrical & Computer Engineering and Bioengineering at the University of Illinois, Urbana-Champaign, and the University of California, San Diego, respectively. Dr. Coleman’s research is very multi-disciplinary, using tools from applied probability, physiology, and bioelectronics. Examples include, for instance, optimal transport methods in high-dimensional uncertainty quantification and developing technologies and algorithms to monitor and modulate physiology of the nervous systems in the brain and visceral organs. He has served as a Principal Investigator on grants from the NSF, NIH, Department of Defense, and multiple private foundations. Dr. Coleman is an inventor on 10 granted US patents. He has been selected as a Gilbreth Lecturer for the National Academy of Engineering, a TEDMED speaker, and a Fellow of IEEE as well as the American Institute for Medical and Biological Engineering. He recently served as Chair of the National Academies Standing Committee on Biotechnology Capabilities and National Security Needs.
-
Ruben J Colman, MD, PhD
Assistant Professor of Pediatrics (Gastroenterology)
BioDr. Colman is a pediatric gastroenterologist and physician-scientist with an overarching goal to improve and optimize the quality of care and outcomes for children with inflammatory bowel diseases (IBD) through precision medicine approaches. His interdisciplinary team science research program focuses on making precision medicine clinically actionable through innovative solutions merging clinical pharmacology knowledge with ‘-omics’ discoveries using microbiome and metabolomics signatures. Part of this work includes translating these findings into improved clinical treat-to-target endpoints with immediate noninvasive point-of-care measures such as intestinal ultrasound.
The foundation of his current work originates from his PhD titled ‘Precision Dosing and Personalized Medicine in pediatric IBD’. During his training, Dr. Colman was also an American Gastroenterological Association (AGA) editorial fellow for Gastroenterology and he is actively involved in the committees of several professional societies including the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), the Crohn’s and Colitis Foundation and the International Bowel UltraSound (IBUS) Group. Dr. Colman is supported by a Career Development K23 Award from the NIH, which focuses on evaluating personalized treatment strategies for children with Crohn's disease, specifically examining microbial and transmural intestinal ultrasound findings. He is also funded by awards of the NASPGHAN Foundation and the Stanford Pediatrics Physician-Scientist Bridge to K Program. -
Christopher H. Contag
Professor of Pediatrics (Neonatology), Emeritus
Current Research and Scholarly InterestsWe develop and use the tools of molecular imaging to understand oncogenesis, reveal patterns of cell migration in immunosurveillance, monitor gene expression, visualize stem cell biology, and assess the distribution of pathogens in living animal models of human biology and disease. Biology doesn't occur in "a vacuum" or on coated plates--it occurs in the living body and that's were we look for biological patterns and responses to insult.
-
John P. Cooke, MD, PhD
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly InterestsOur translational research program in vascular regeneration is focused on generating and characterizing vascular cells from human induced pluripotential stem cells. We are also studying the therapeutic application of these cells in murine models of peripheral arterial disease. In these studies we leverage our longstanding interest in endothelial signaling, eg by nitric oxide synthase (NOS) as well as by nicotinic cholinergic receptors (nAChR).
-
Margaret Cooke, MD
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Cooke is a clinical assistant professor in the Department of Orthopaedic Surgery at Stanford University School of Medicine. She has a strong clinical interest in hand, wrist, and elbow surgery for adult and pediatric patients. She is dual fellowship trained in Hand & Upper Extremity Surgery and Pediatric & Congenital Hand Surgery.
As an orthopaedic surgeon, Dr. Cooke’s goal is to alleviate pain and improve hand, wrist, and elbow function so that her patients can return to the activities they enjoy. Her primary clinical interests are nerve compression (carpal tunnel), nerve injuries (traumatic/lacerations), joint instability/arthritis (degenerative conditions of the hand wrist and elbow), sports/athletic injuries, fracture care, and pediatric & congenital conditions of the hand and upper extremity.
Dr. Cooke utilizes a multi-disciplinary approach in order to provide comprehensive care for each patient. She works closely with colleagues from oncology, radiology, physical therapy, and other specialties. Her team includes certified hand therapists, cast technicians, medical assistants, and patient care coordinators. Together, Dr. Cooke and her team are committed to providing the best possible care for patients.
She invites patient referrals as early as possible when an upper extremity problem is suspected. She ensures a trusting relationship with referring physicians (whether primary care providers or specialists) by staying in communication so they understand and are comfortable with her recommendations.
In addition to patient care, Dr. Cooke has enjoyed contributing to her field through research. Among Dr. Cooke’s clinical research interests is fracture healing, including gene expression following administration of medication to stimulate bone repair. She has authored articles on topics like infection prediction and pain management after surgical repair of fractures. Her work has appeared in the Journal of Orthopaedic Trauma, Journal of Orthopaedic Research, Osteoarthritis & Cartilage, Spine, and Transplantation. She also co-wrote the chapter “The History of Carpal Tunnel” for the textbook Carpal Tunnel Syndrome and Related Median Neuropathies.
Dr. Cooke’s honors include a Howard Hughes Research Fellowship, an Outstanding Chief Resident Research Award, and recognition for authoring one of the top ten Foot & Ankle research papers at the 2016 American Academy of Orthopaedic Surgeons conference.
In addition to her practice in the U.S., Dr. Cooke has traveled abroad as a physician volunteer to provide surgical services in underserved areas where there is no access to hand surgery specialists. In partnership with the surgeon-founded nonprofit organization Touching Hands, she has performed hand surgeries on adult and pediatric patients in Honduras. Dr. Cooke also has traveled with Shriners Hospital to treat children in Davao, Philippines. -
David N. Cornfield
Anne T. and Robert M. Bass Professor of Pediatric Pulmonary Medicine
Current Research and Scholarly InterestsOver the past 20 years, the Cornfield Laboratory has focused upon basic, translational and clinical research, with a primary focus on lung biology. As an active clinician-scientist, delivering care to acutely and chronically ill infants and children, our lab focuses on significant clinical challenges and tried to use science to craft novel solutions to difficult clinical problems.
-
Steven M. Corsello
Assistant Professor of Medicine (Oncology)
Current Research and Scholarly InterestsOur laboratory operates at the intersection of functional genomics and chemical biology, with the goal of advancing novel molecular mechanisms of cancer inhibition to clinical use. We aim to 1) leverage phenotypic screening and functional genomics to determine novel anti-cancer mechanisms of small molecules, 2) develop new targeted therapy approaches against solid tumors, and 3) build a comprehensive community resource for drug repurposing discovery.
-
Victoria Cosgrove
Assistant Professor of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Child Development)
Current Research and Scholarly InterestsDr. Cosgrove studies putative roles for life and family stress as well as inflammatory and neurotrophic pathways in the etiology and development of mood disorders across the life span.
-
Helio Costa
Affiliate, Biomedical Informatics (BMI) graduate training program
BioHelio Costa, PhD, is a medical geneticist specializing in oncology, genomics, computational biology, data science, artificial intelligence, and product development. His work focuses on developing new cancer therapies and medical software to improve cancer patient care. He currently serves as Senior Medical Director and Head of Molecular Therapeutics & Drug Development at Natera and is an Adjunct Clinical Assistant Professor in the Department of Pathology at Stanford Medical School.
Dr. Costa’s research spans the entire drug development pipeline, from discovery to FDA-approved therapies. He leads efforts in developing innovative cancer treatments by integrating advanced genomics, computational biology, and AI-driven methodologies. His team focuses on the creation of targeted molecular therapeutics, using large-scale genetic data to identify novel treatment pathways and predict patient responses. In addition to drug discovery, Dr. Costa oversees the clinical trials necessary for validating these therapies, ensuring they meet rigorous standards for safety and efficacy. Furthermore, he manages the product development and commercialization process, guiding new treatments from initial research through to market-ready, FDA-approved cancer therapies.
In addition to his therapeutic work, Dr. Costa has led the development and implementation of genetic diagnostic tests and clinical algorithms used to support therapeutic decisions at Stanford Health Care. His contributions include the creation of DNA and RNA cancer diagnostic tests, as well as algorithms that analyze large-scale laboratory datasets and electronic medical records to predict patient outcomes. As a co-investigator with the NIH Clinical Genome Resource (ClinGen) Consortium, Dr. Costa oversaw developing FDA-recognized medical software used by healthcare providers, researchers, and biotech companies to assess the clinical relevance of genes and mutations.
He is the founding director of the Stanford Clinical Data Science Fellowship, where post-doctoral medical fellows engage in interdisciplinary clinical research and implement real-world health data solutions within Stanford Health Care. Dr. Costa is also an Attending Medical Geneticist for the Molecular Genetic Pathology Laboratory at Stanford Health Care, where he previously served as Assistant Lab Director.
Dr. Costa holds a BS in Genetics from the University of California, Davis, a PhD in Genetics from Stanford University School of Medicine, and completed his ABMGG Clinical Molecular Genetics and Genomics fellowship training at Stanford University School of Medicine. -
Tina Cowan
Professor of Pathology (Clinical) and, by courtesy, of Pediatrics (Genetics)
Current Research and Scholarly Interestsscreening and diagnosis of patients with inborn errors of metabolism, including newborn screening, development of new testing methods and genotype/phenotype correlations.
-
Kenneth L. Cox
Professor of Pediatrics (Gastroenterology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsGastroenterology, biliary motility, hormonal regulation, embryology, gastrointestinal tract, clinical management of pediatric liver transplant recipients.
-
Alia Crum
Associate Professor of Psychology and, by courtesy, of Medicine (Primary Care & Population Health)
Current Research and Scholarly InterestsOur lab focuses on how subjective mindsets (e.g., thoughts, beliefs and expectations) can alter objective reality through behavioral, psychological, and physiological mechanisms. We are interested in understanding how mindsets affect important outcomes both within and beyond the realm of medicine, in the domains such as exercise, diet and stress. https://mbl.stanford.edu/
-
Meg Cychosz
Assistant Professor of Linguistics
BioDr. Cychosz investigates how infants and children develop speech and language, including children who are d/Deaf or hard-of-hearing and multilingual learners. Her research bridges linguistics, cognitive science, developmental psychology, and electrical engineering to understand fundamental questions about language acquisition. Her interdisciplinary approach combines fieldwork with computational methods, using deep learning and automatic speech recognition tools to analyze naturalistic speech recordings from children's daily lives. She is particularly interested in how children's processing limitations might influence the structure of the world's languages, how sensory experiences like hearing loss affect language processing in early childhood, and how technological innovations can make language research more accessible and representative. Dr. Cychosz directs the Speech and Cognitive Development Lab and collaborates with clinical partners in audiology and speech-language pathology to ensure her research has translational impact to support children's language development.
-
Agnieszka Czechowicz, MD, PhD
Assistant Professor of Pediatrics (Stem Cell Transplantation)
Current Research and Scholarly InterestsDr. Czechowicz’s research is aimed at understanding how hematopoietic stem cells interact with their microenvironment in order to subsequently modulate these interactions to improve bone marrow transplantation and unlock biological secrets that further enable regenerative medicine broadly. This work can be applied across a variety of disease states ranging from rare genetic diseases, autoimmune diseases, solid organ transplantation, microbiome-augmentation and cancer.
-
Gary Dahl
Professor of Pediatrics (Hematology/Oncology), Emeritus
Current Research and Scholarly InterestsHematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.
-
Jeremy Dahl
Professor of Radiology (Pediatric Radiology)
Current Research and Scholarly InterestsMy current research encompasses ultrasonic beamforming and image reconstruction methods, with application areas in improving ultrasound image quality in difficult-to-image patients and ultrasound molecular imaging of cancer. My lab also employs beamforming concepts to enhance other areas of ultrasound research.
-
Hongjie Dai
The J.G. Jackson and C.J. Wood Professor of Chemistry, Emeritus
BioProfessor Dai’s research spans chemistry, physics, and materials and biomedical sciences, leading to materials with properties useful in electronics, energy storage and biomedicine. Recent developments include near-infrared-II fluorescence imaging, ultra-sensitive diagnostic assays, a fast-charging aluminum battery and inexpensive electrocatalysts that split water into oxygen and hydrogen fuels.
Born in 1966 in Shaoyang, China, Hongjie Dai began his formal studies in physics at Tsinghua U. (B.S. 1989) and applied sciences at Columbia U. (M.S. 1991). He obtained his Ph.D. from Harvard U and performed postdoctoral research with Dr. Richard Smalley. He joined the Stanford faculty in 1997, and in 2007 was named Jackson–Wood Professor of Chemistry. Among many awards, he has been recognized with the ACS Pure Chemistry Award, APS McGroddy Prize for New Materials, Julius Springer Prize for Applied Physics and Materials Research Society Mid-Career Award. He has been elected to the American Academy of Arts and Sciences, National Academy of Sciences (NAS), National Academy of Medicine (NAM) and Foreign Member of Chinese Academy of Sciences.
The Dai Laboratory has advanced the synthesis and basic understanding of carbon nanomaterials and applications in nanoelectronics, nanomedicine, energy storage and electrocatalysis.
Nanomaterials
The Dai Lab pioneered some of the now-widespread uses of chemical vapor deposition for carbon nanotube (CNT) growth, including vertically aligned nanotubes and patterned growth of single-walled CNTs on wafer substrates, facilitating fundamental studies of their intrinsic properties. The group developed the synthesis of graphene nanoribbons, and of nanocrystals and nanoparticles on CNTs and graphene with controlled degrees of oxidation, producing a class of strongly coupled hybrid materials with advanced properties for electrochemistry, electrocatalysis and photocatalysis. The lab’s synthesis of a novel plasmonic gold film has enhanced near-infrared fluorescence up to 100-fold, enabling ultra-sensitive assays of disease biomarkers.
Nanoscale Physics and Electronics
High quality nanotubes from his group’s synthesis are widely used to investigate the electrical, mechanical, optical, electro-mechanical and thermal properties of quasi-one-dimensional systems. Lab members have studied ballistic electron transport in nanotubes and demonstrated nanotube-based nanosensors, Pd ohmic contacts and ballistic field effect transistors with integrated high-kappa dielectrics.
Nanomedicine and NIR-II Imaging
Advancing biological research with CNTs and nano-graphene, group members have developed π–π stacking non-covalent functionalization chemistry, molecular cellular delivery (drugs, proteins and siRNA), in vivo anti-cancer drug delivery and in vivo photothermal ablation of cancer. Using nanotubes as novel contrast agents, lab collaborations have developed in vitro and in vivo Raman, photoacoustic and fluorescence imaging. Lab members have exploited the physics of reduced light scattering in the near-infrared-II (1000-1700nm) window and pioneered NIR-II fluorescence imaging to increase tissue penetration depth in vivo. Video-rate NIR-II imaging can measure blood flow in single vessels in real time. The lab has developed novel NIR-II fluorescence agents, including CNTs, quantum dots, conjugated polymers and small organic dyes with promise for clinical translation.
Electrocatalysis and Batteries
The Dai group’s nanocarbon–inorganic particle hybrid materials have opened new directions in energy research. Advances include electrocatalysts for oxygen reduction and water splitting catalysts including NiFe layered-double-hydroxide for oxygen evolution. Recently, the group also demonstrated an aluminum ion battery with graphite cathodes and ionic liquid electrolytes, a substantial breakthrough in battery science. -
Heike Daldrup-Link
Professor of Radiology (General Radiology) and, by courtesy, of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsAs a physician-scientist involved in the care of pediatric patients and developing novel pediatric molecular imaging technologies, my goal is to link the fields of nanotechnology and medical imaging towards more efficient diagnoses and image-guided therapies. Our research team develops novel imaging techniques for improved cancer diagnosis, for image-guided-drug delivery and for in vivo monitoring of cell therapies in children and young adults.
-
Roxana Daneshjou, MD, PhD
Assistant Professor of Biomedical Data Science and of Dermatology and, by courtesy, of Radiology
BioDr. Daneshjou studied Bioengineering at Rice University before matriculating to Stanford School of Medicine where she completed her MD and a PhD in Genetics with Dr. Russ Altman as part of the medical scientist training program. She completed dermatology residency at Stanford as part of the research track and completed a postdoc in Biomedical Data Science with Dr. James Zou. She currently is the assistant director of the Center of Excellence for Precision Heath & Pharmacogenomics, director of informatics for the Stanford Skin Innovation and Interventional Research Group (SIIRG), a founding member of the Translational AI in Dermatology (TRAIND) group, and a faculty affiliate of Human-centered Artificial Intelligence (HAI) and the AI in Medicine and Imaging (AIMI) centers.
-
Rebecca Dang
Instructor, Pediatrics
BioDr. Rebecca Dang is an Instructor in the Division of General Pediatrics at Stanford University. She earned her medical degree at Georgetown School of Medicine and completed her pediatric residency at Kaiser Permanente Northern California. She also completed pediatric hospital medicine fellowship and a master’s program in clinical research and epidemiology at Stanford University. Dr. Dang provides clinical care for children on the pediatric ward and newborn nursery.
Dr. Dang’s research interest focuses on high-value pediatric care, which she hopes to improve through building evidence for common, understudied practices. Common practices that are ubiquitous throughout pediatric medicine are temperature measurement and management. Despite temperature measurement and the subsequent detection of ‘normal’ or ‘abnormal’ values driving clinical decision making, these temperature thresholds may be outdated or poorly defined. Dr. Dang has led many projects on temperature-related topics, including routine temperature measurement at well-child visits, pediatric temperature percentiles, risk factors for and outcomes of neonatal hypothermia in the newborn nursery, and newborn temperature norms. This work has led to first-author publications in the high-impact journals of Academic Pediatrics, Pediatrics, Journal of Pediatrics, JAMA Network Open, and Hospital Pediatrics. She has secured continual institutional and foundation funding, including a Maternal & Child Health Research Institute clinical trainee award and master’s tuition program, Gerber Foundation main and novice research award, the Department of Pediatrics’ Bridge-to-K Program, and the PEDSnet Scholars Program. -
Kyle Gabriel Daniels
Assistant Professor of Genetics and, by courtesy, of Neurosurgery (Adult Neurosurgery)
BioKyle obtained his BS in Biochemistry from the University of Maryland College Park in 2010, conducting undergraduate research with Dr. Dorothy Beckett, PhD. He obtained his PhD in Biochemistry with a certificate in Structural Biology and Biophysics. His dissertation is titled "Kinetics of Coupled Binding and Conformational Change in Proteins and RNA" and was completed in the laboratory of Dr. Terrence G. Oas, PhD. Kyle performed postdoctoral training with Dr. Wendell A. Lim, PhD at UCSF studying how CAR T cell phenotype is encoded by modular signaling motifs within chimeric antigen receptors.
Kyle's lab is interested in harnessing the principles of modularity to engineer receptors and gene circuits to control cell functions.
The lab will use synthetic biology, medium- and high-throughput screens, and machine learning to: (1) Engineer immune cells to achieve robust and durable responses against various cancer targets, (2) Coordinate behavior of multiple engineered cell types in cancer, autoimmune disease, and payload delivery, (3) Control survival, proliferation, and differentiation of hematopoietic stem cells (HSCs) and immune cells, and (4) Explore principles of modularity related to engineering receptors and gene circuits in mammalian cells. -
Muhammad Najam Dar
Affiliate, Ophthalmology Research/Clinical Trials
BioDr. Muhammad Najam Dar is affiliate researcher at Stanford University and specializing in electrophysiological signal-based ophthalmological solutions. He holds a Ph.D. in Computer Engineering from the National University of Sciences and Technology (NUST), Pakistan, and was awarded the prestigious Erasmus Mundus Fellowship for his doctoral research at City, University of London, United Kingdom.
With a strong interdisciplinary foundation in biomedical signal and image analysis, computer vision, and deep learning, Dr. Dar has made significant contributions to both academia and industry. His research focuses on developing cutting-edge AI-driven diagnostic tools, wearable smart device signal processing, and systemic workflow optimizations for healthcare applications. His work integrates machine learning, medical imaging, and human-centered design to advance next-generation ophthalmological and biomedical solutions.
Beyond research, Dr. Dar has extensive experience in teaching, mentorship, and academic leadership, fostering innovation in AI-driven healthcare among the next generation of engineers and scientists. His ability to bridge theoretical knowledge with real-world applications makes him an invaluable asset in advancing biomedical engineering, artificial intelligence in healthcare, and translational research. Dr. Dar aims to become a leader in AI-driven healthcare solutions by advancing cutting-edge research, fostering industry collaborations, integrating design thinking into innovative medical technologies, mentoring and inspiring students and peers, empowering them to to drive transformative advancements in healthcare and improve lives globally. -
Gary Darmstadt
Sue Alvarez Professor of Neonatal and Developmental Medicine and Professor (Teaching), by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly InterestsI have extensive experience in the development of global health innovations and in working to test and scale-up health interventions. At Stanford University, I am playing a leading role in developing global women and children’s health research and educational programs, including the establishment of a Global Center for Gender Equality at Stanford University. My research focuses on advancing child health and development in low resource settings and advancing gender equality and health globally, and includes several applications of artificial intelligence. Before joining Stanford, I was Senior Fellow at the Bill & Melinda Gates Foundation (BMGF), where I led the development of initiatives to address gender inequalities and empower women and girls. Prior to this role, I served as the BMGF Director of Family Health, leading strategy development and implementation across maternal, newborn and child health, nutrition, and family planning. In this role, I was responsible for investments ranging from scientific discovery to intervention development and delivery of interventions at scale. I worked closely with the Discovery team to shape discovery and development investments and was a co-founder of the Saving Lives at Birth Development Grand Challenge, the Putting Women and Girls at the Center of Development Grand Challenge, and the Healthy Birth, Growth and Development initiative. Based on these experiences, I understand how to identify knowledge gaps and generate evidence of impact for new interventions, and how to utilize evidence to influence the policy dialogue leading to programmatic adoption and scale-up of interventions in low income settings. As Director of Family Health, I also co-led the development and implementation of the BMGF global health strategy for India, which cuts across multiple health and development sectors. Before joining BMGF, I was Associate Professor and Founding Director of the International Center for Advancing Neonatal Health in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health. I led the development of newborn health research, including numerous facility- and community-based maternal and child health research trials. Before joining Johns Hopkins, I was Senior Research Advisor for the $50M Saving Newborn Lives program of Save the Children-US, where I led the development and implementation of the global research strategy for newborn health and survival.
-
Laura M.K. Dassama
Assistant Professor of Chemistry and of Microbiology and Immunology
BioLaura Dassama is a chemical biologist who uses principles from chemistry and physics to understand complex biological phenomena. Her group’s primary goal is to use detailed understanding of the factors that enable interactions between biological molecules to provide insights that allow functional control of those molecules. Her research projects aim to 1) discover the drivers of biomolecular interactions and 2) leverage that information to modulate disease relevant proteins.
-
Jenna Davis
Professor of Civil and Environmental Engineering, of Environmental Social Sciences and Higgins-Magid Senior Fellow at the Woods Institute
Current Research and Scholarly InterestsProfessor Davis’ research and teaching deals broadly with the role that water plays in promoting public health and economic development, with particular emphasis on low- and middle-income countries. Her group conducts applied research that utilizes theory and analytical methods from public and environmental health, engineering, microeconomics, and planning. They have conducted field research in more than 20 countries, most recently including Zambia, Bangladesh, and Kenya.
-
Kara Davis
Associate Professor of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsChildhood cancers can be considered aberrations of normal tissue development. We are interested in understanding childhood cancers through the lens of normal development. Further, individual tumors are composed of heterogeneous cell populations, not all cells being equal in their ability to respond to treatment or to repopulate a tumor. Thus, we take single cell approach to determine populations of clinical relevance.
-
Mark M. Davis
Burt and Marion Avery Family Professor
Current Research and Scholarly InterestsMolecular mechanisms of lymphocyte recognition and differentiation; Systems immunology and human immunology; vaccination and infection.
-
Ronald W. Davis
Professor of Biochemistry and of Genetics
Current Research and Scholarly InterestsWe are using Saccharomyces cerevisiae and Human to conduct whole genome analysis projects. The yeast genome sequence has approximately 6,000 genes. We have made a set of haploid and diploid strains (21,000) containing a complete deletion of each gene. In order to facilitate whole genome analysis each deletion is molecularly tagged with a unique 20-mer DNA sequence. This sequence acts as a molecular bar code and makes it easy to identify the presence of each deletion.
-
John W. Day, MD, PhD
Professor of Neurology and Neurological Sciences (Adult Neurology), of Pediatrics (Genetics) and, by courtesy, of Pathology
On Partial Leave from 02/15/2026 To 10/18/2026Current Research and Scholarly InterestsOur Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.
-
Vinicio de Jesus Perez MD
Associate Dean of Stanford MD Admissions and Professor of Medicine (PACCM)
Current Research and Scholarly InterestsMy work is aimed at understanding the molecular mechanisms involved in the development and progression of pulmonary arterial hypertension (PAH). I am interested in understanding the role that the BMP and Wnt pathways play in regulating functions of pulmonary endothelial and smooth muscle cells both in health and disease.
-
Luis de Lecea
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical and Translational Neurosciences Incubator)
Current Research and Scholarly InterestsMy lab uses molecular, optogenetic, anatomical and behavioral methods to identify and manipulate the neuronal circuits underlying brain arousal, with particular attention to sleep and wakefulness transitions. We are also interested in the changes that occur in neuronal circuits in conditions of hyperarousal such as stress and drug addiction.
-
Maharshi Krishna Deb
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsI aim to gain insights of the molecular underpinnings that are critical for the specification of human germ cells as well as the episode of epigenetic reprogramming that they undergo which is critical for their development and thereby essential for perpetual propagation of human species. Under co-mentorship of Prof. Azim Surani and Dr. Shiv Grewal,I aim to learn these lessons from this immortal lineage of human germline to identify interventions against various pediatric as well as degenerative
-
Cornelia L. Dekker, M.D.
Professor (Research) of Pediatrics (Infectious Diseases), Emerita
Current Research and Scholarly InterestsThe Stanford-LPCH Vaccine Program provides an infrastructure for conducting clinical studies of vaccines in children and adults. We conduct immunology studies of seasonal influenza vaccines in twins, in a longitudinal cohort of young and elderly adults and studies of various vaccine candidates for NIH and industry. Additionally, we were a CDC Clinical Immunization Safety Assessment site for 10 years working on safety issues concerning licensed vaccines.
-
Claudia Del Toro Runzer
Postdoctoral Scholar, Medical Genetics
BioClaudia Del Toro Runzer is a postdoctoral scholar at Stanford University specializing in gene therapy and regenerative medicine. Her current research focuses on developing gene editing strategies for inherited disorders, including GNE myopathy and Gaucher disease. She works on advancing precision gene engineering approaches in human hematopoietic stem and progenitor cells and other clinically relevant cell types, with the goal of enabling safe and durable therapeutic correction.
Dr. Del Toro Runzer earned her PhD in Tissue Engineering from the MERLN Institute for Technology-Inspired Regenerative Medicine at Maastricht University. Her doctoral research focused on chemically modified mRNA therapeutics for bone regeneration, where she investigated molecular design, intracellular trafficking, and biomaterial-assisted delivery systems to enhance protein expression and osteogenic outcomes. Her work resulted in multiple first-author publications in leading journals, including Advanced Functional Materials, Bone Research, Materials Today, and Molecular Therapy: Nucleic Acids.
Prior to her PhD, she completed an M.Sc. in Regenerative Biology and Medicine at Technische Universität Dresden and a B.Sc. in Biotechnology Engineering at Instituto Tecnológico de Monterrey. Her international training spans Germany, the Netherlands, Mexico, and the United States, with research experience in organoid systems, tissue regeneration, biomaterials engineering, and microphysiological platforms. -
Scott L. Delp, Ph.D.
Director, Wu Tsai Human Performance Alliance at Stanford, James H. Clark Professor in the School of Engineering, Professor of Bioengineering and of Mechanical Engineering
Current Research and Scholarly InterestsExperimental and computational approaches to study human movement. Development of biomechanical models to analyze muscle function, study movement abnormalities, design medical products, and guide surgery. Imaging and health technology development. Discovering the principles of peak performance to advance human health. Human performance research. Wearable technologies, video motion capture, and machine learning to enable large-scale analysis.
-
Utkan Demirci
Professor of Radiology (Diagnostic Sciences Laboratory) and, by courtesy, of Electrical Engineering
BioDr. Utkan Demirci, UofM’99, Stanford’01’05’05, is a Professor of Radiology (with tenure) and of Electrical Engineering (by courtesy) at the Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, where he leads a productive researcher group. Utkan is a tenured professor at Stanford University School of Medicine. Prior to joining Stanford in 2014, he held the position of Associate Professor at the Brigham and Women’s Hospital-Harvard Medical School and also served at the Harvard-MIT Health Sciences and Technology division. Over the past decade, his research group has focused on the early detection of cancer and has made significant contributions to the development of microfluidic platforms for sorting rare cells and exosomes and point-of-care bio-sensing technologies.
Dr. Demirci leads a productive and impactful research group focused on addressing problems from the clinic with innovations including cell sorter for IVF, optical technologies for detecting viruses, portable point of care technologies for diagnostics in global health, smart robots in vivo, extracellular vesicle based early detection approaches for cancer. He is an elected fellow of the American Institute of Medical and Biological Engineering and The Academy for Radiology & Biomedical Imaging Research Distinguished Investigator.
He has published over 250 peer-reviewed articles, 300 abstracts and proceedings, 24 book chapters and editorials, and 7 edited books. He also serves on the editorial board of various journals. He is a serial academic entrepreneur and co-founded multiple successful companies. His patents are translated into broadly used biomedical products. Dr. Demirci's pioneering work in microfluidics and cell sorting has resulted in CE certified and FDA approved devices used in over 500,000 clinical cases serving patients globally. -
Dr. Qiwen Deng
Postdoctoral Scholar, Pathology
BioMy research aims to understand how immune–stromal interactions shape tissue injury, repair, and fibrosis across chronic diseases. I combine multiplexed spatial proteomics (CODEX), single-cell and spatial transcriptomics, and molecular pathology approaches to dissect the organization and function of complex tissue microenvironments. By mapping spatially resolved cellular neighborhoods in human biopsies, I seek to uncover conserved and disease-specific patterns that can guide biomarker discovery and therapeutic development.
Working within a laboratory focused on the mechanisms and therapeutic targeting of fibrotic diseases, I investigate chronic kidney disease alongside other models of organ fibrosis. With a background spanning molecular biology, therapeutic development, and spatial biology, I aim to advance studies that connect detailed tissue analysis with potential clinical applications. I welcome opportunities for collaborative research in chronic kidney disease and other fibrosis-related conditions. -
Manisha Desai (She/Her/Hers)
Kim and Ping Li Professor, Professor (Research) of Medicine (Quantitative Sciences Unit), of Biomedical Data Science and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Desai is the Director of the Quantitative Sciences Unit. She is interested in the application of biostatistical methods to all areas of medicine including oncology, nephrology, and endocrinology. She works on methods for the analysis of epidemiologic studies, clinical trials, and studies with missing observations.
-
Tushar Desai
Professor of Medicine (Pulmonary, Allergy and Critical Care Medicine)
Current Research and Scholarly InterestsBasic and translational research in lung stem cell biology, cancer, pulmonary fibrosis, COPD, and acute lung injury/ARDS. Upper airway stem cell CRISPR gene correction followed by autologous stem cell transplantation to treat Cystic fibrosis. Using lung organoids and precision cut lung slice cultures of mouse and human lungs to study molecular regulation of lung stem cells. Using transgenic mice to visualize Wnt protein transmission from niche cell to stem cell in vivo.
-
Joseph M. DeSimone
Sanjiv Sam Gambhir Professor of Translational Medicine, Professor of Chemical Engineering and, by courtesy, of Chemistry, of Materials Science and Engineering, and of Operations, Information and Technology at the Graduate School of Business
BioJoseph M. DeSimone is the Sanjiv Sam Gambhir Professor of Translational Medicine and Chemical Engineering at Stanford University. He holds appointments in the Departments of Radiology and Chemical Engineering with courtesy appointments in the Department of Chemistry and in Stanford’s Graduate School of Business.
The DeSimone laboratory's research efforts are focused on developing innovative, interdisciplinary solutions to complex problems centered around advanced polymer 3D fabrication methods. In Chemical Engineering and Materials Science, the lab is pursuing new capabilities in digital 3D printing, as well as the synthesis of new polymers for use in advanced additive technologies. In Translational Medicine, research is focused on exploiting 3D digital fabrication tools to engineer new vaccine platforms, enhanced drug delivery approaches, and improved medical devices for numerous conditions, with a current major focus in pediatrics. Complementing these research areas, the DeSimone group has a third focus in Entrepreneurship, Digital Transformation, and Manufacturing.
Before joining Stanford in 2020, DeSimone was a professor of chemistry at the University of North Carolina at Chapel Hill and of chemical engineering at North Carolina State University. He is also Co-founder, Board Chair, and former CEO (2014 - 2019) of the additive manufacturing company, Carbon. DeSimone is responsible for numerous breakthroughs in his career in areas including green chemistry, medical devices, nanomedicine, and 3D printing. He has published over 350 scientific articles and is a named inventor on over 200 issued patents. Additionally, he has mentored 80 students through Ph.D. completion in his career, half of whom are women and members of underrepresented groups in STEM.
In 2016 DeSimone was recognized by President Barack Obama with the National Medal of Technology and Innovation, the highest U.S. honor for achievement and leadership in advancing technological progress. He has received numerous other major awards in his career, including the U.S. Presidential Green Chemistry Challenge Award (1997); the American Chemical Society Award for Creative Invention (2005); the Lemelson-MIT Prize (2008); the NIH Director’s Pioneer Award (2009); the AAAS Mentor Award (2010); the Heinz Award for Technology, the Economy and Employment (2017); the Wilhelm Exner Medal (2019); the EY Entrepreneur of the Year Award (2019 U.S. Overall National Winner); and the Harvey Prize in Science and Technology (2020). He is one of only 25 individuals elected to all three branches of the U.S. National Academies (Sciences, Medicine, Engineering). DeSimone received his B.S. in Chemistry in 1986 from Ursinus College and his Ph.D. in Chemistry in 1990 from Virginia Tech. -
Gurpreet Singh Dhillon
Clinical Associate Professor, Pediatrics - Cardiology
BioResearch interest in pediatric resuscitation science, with the goal of improving outcomes for children with heart disease experiencing cardiac arrest.
-
Chitra Dinakar
Member, Maternal & Child Health Research Institute (MCHRI)
BioDr. Chitra Dinakar is a Clinical Professor of Medicine at Stanford University and the Clinical Chief of Allergy, Asthma and Immunodeficiency, Stanford Health Care. Prior to coming to Stanford she was a Professor of Pediatrics at the University of Missouri-Kansas City; and Director, Food Allergy Center at Children’s Mercy Hospital, Kansas City. She completed her fellowship in Allergy/Immunology (A/I) at the Cleveland Clinic Foundation, Ohio, and her residency in pediatrics at Case Western Reserve University/Metrohealth Medical Center, Ohio. She completed her medical school and pediatric residency training at JIPMER, a premier medical institution in India.
Having had the benefit of experiencing health care in diverse settings, Dr. Dinakar is empowered with the perspective, and driven by the passion, to improve health care across the globe. Her interests and expertise include food allergies, asthma, and health care disparities, delivery, and outcomes. She serves on the editorial boards of four reputed Allergy/Immunology journals and the World Allergy Organization Web Editorial Board. She has been involved in more than 50 multi-centered, clinical trials relating to asthma and food allergies, and has over 100 peer-reviewed publications and research abstracts in prestigious journals.
One of her current research interests is ASIAd (Allergy/Asthma Studies in Individuals of Asian Descent), that explores the Care, Cure and Prevention of Allergic conditions in individuals of Asian lineage. As part of the exploration she is collaborating with researchers from Northwestern University to study the unique food allergens prevalent in the South Asian population (please click on link: https://www.surveymonkey.com/s/SouthAsianFoodAllergySurvey). She hopes to address the significant knowledge gaps and unmet needs regarding diagnostic, treatment and preventive options available to this demographic group. Another current area of focus is development of tools to improve patient outcomes in food allergic disorders; she recently received a grant to support phase I of the project. Her other ongoing research interests include the health impact of e-cigarettes, clinical intervention trials and outcomes research in asthma, and use of e-health to improve patient outcomes.
She is an invited speaker at national and international allergy conferences, and serves on the Board of Directors at national A/I organizations [American Board of A/I; American Academy of A/I; Joint A/I Task Force on Practice Parameters; American Academy of Pediatrics Section of A/I]. Dr. Dinakar’s honors include the following national awards: ”Distinguished Fellow", "Woman in Allergy", “Acellus Teacher of the Year”, "Award of Excellence", and an honorary “Kentucky Colonel” awarded by the Governor of Kentucky, “Best Doctors in America”, and “Kansas City SuperDocs”. -
Jun Ding
Professor of Neurosurgery and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsNeural circuits of movement control in health and movement disorders
-
Xiruo Ding
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioI am a postdoctoral scholar at Stanford University, advised by Dr. Nima Aghaeepour, focusing on EHR-related modeling and phenotyping. My research interests lie in the application of general machine learning and deep learning methods to enhance healthcare outcomes.
-
Patricia Dionicio
Postdoctoral Scholar, Pediatric Anesthesia
BioPatricia Dionicio, PhD, MPH is a postdoctoral fellow in the Department of Anesthesiology, Perioperative and Pain Medicine in the School of Medicine at Stanford University. Her research aims to reduce health disparities in pain among underserved populations through human-centered design and digital interventions. She has expertise in integrating mixed methods with longitudinal assessment tools to understand systemic and momentary factors impacting health behavior.
-
Elizabeth DiRenzo, PhD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Music
Current Research and Scholarly InterestsDr. Erickson DiRenzo's laboratory integrates research techniques from the basic and clinical sciences to improve the prevention and management of voice disorders.
-
Anjali Dixit, MD, MPH
Instructor, Anesthesiology, Perioperative and Pain Medicine
BioI am a pediatric anesthesiologist and health services researcher. My research focuses on outcomes in pediatric and adult surgical patients, management of pain and use of opioids in the perioperative period, and prevention and treatment of substance use disorders. My clinical care and research are both grounded in a desire to provide safe, equitable healthcare to all patients, particularly during high-risk or stressful events such as surgery.
-
Amy D. Dobberfuhl, MD, MS
Assistant Professor of Urology
Current Research and Scholarly InterestsDr. Dobberfuhl's current clinical practice includes: Pelvic Reconstruction, Neurourology, and Voiding Dysfunction.
-
Dylan Dodd
Associate Professor of Pathology and of Microbiology and Immunology
On Leave from 01/05/2026 To 05/05/2026Current Research and Scholarly InterestsHarnessing the gut microbiome to treat human disease.
-
Chunyang Dong
Postdoctoral Scholar, Psychiatry
BioChunyang Dong completed his Ph.D. studies from University of California, Davis with Dr. Lin Tian, where he specialized in protein engineering to develop genetically encoded biosensors to enable real-time imaging of neuromodulator dynamics. As part of his postdoctoral pursuits with Dr. Sergiu Pasca at Stanford University, he hopes to combine disciplines between biosensors and modeling human neurological disease using brain region-specific organoids. Despite this shift, his unwavering goal is to deepen the understanding of brain development, disease processes, and translate research to potential treatments for neurological disorders.
-
David Drover
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD), Emeritus
Current Research and Scholarly InterestsField of clinical pharmacology. This involves analysis of what the body does to a drug (pharmacokinetics) and how exactly a specific drug affects the body (pharmacodynamics). His research starts at the level of new drug development with detailed analysis of the pharmacokinetics and pharmacodynamics of a medication.
-
Maurice L. Druzin
Professor of Obstetrics and Gynecology (Maternal Fetal Medicine and Obstetrics), Emeritus
Current Research and Scholarly InterestsAntepartum and intrapartum fetal monitoring Prenatal diagnosis Medical complications of pregnancy, particularly: SLE, hypertension, diabetes, malignancy A.
-
Justin Du Bois
Henry Dreyfus Professor of Chemistry and Professor, by courtesy, of Chemical and Systems Biology
BioResearch and Scholarship
Research in the Du Bois laboratory spans reaction methods development, natural product synthesis, and chemical biology, and draws on expertise in molecular design, molecular recognition, and physical organic chemistry. An outstanding goal of our program has been to develop C–H bond functionalization processes as general methods for organic chemistry, and to demonstrate how such tools can impact the logic of chemical synthesis. A second area of interest focuses on the role of ion channels in electrical conduction and the specific involvement of channel subtypes in the sensation of pain. This work is enabled in part through the advent of small molecule modulators of channel function.
The Du Bois group has described new tactics for the selective conversion of saturated C–H to C–N and C–O bonds. These methods have general utility in synthesis, making possible the single-step incorporation of nitrogen and oxygen functional groups and thus simplifying the process of assembling complex molecules. To date, lab members have employed these versatile oxidation technologies to prepare natural products that include manzacidin A and C, agelastatin, tetrodotoxin, and saxitoxin. Detailed mechanistic studies of metal-catalyzed C–H functionalization reactions are performed in parallel with process development and chemical synthesis. These efforts ultimately give way to advances in catalyst design. A long-standing goal of this program is to identify robust catalyst systems that afford absolute control of reaction selectivity.
In a second program area, the Du Bois group is exploring voltage-gated ion channel structure and function using the tools of chemistry in combination with those of molecular biology, electrophysiology, microscopy and mass spectrometry. Much of this work has focused on studies of eukaryotic Na and Cl ion channels. The Du Bois lab is interested in understanding the biochemical mechanisms that underlie channel subtype regulation and how such processes may be altered following nerve injury. Small molecule toxins serve as lead compounds for the design of isoform-selective channel modulators, affinity reagents, and fluorescence imaging probes. Access to toxins and modified forms thereof (including saxitoxin, gonyautoxin, batrachotoxin, and veratridine) through de novo synthesis drives studies to elucidate toxin-receptor interactions and to develop new pharmacologic tools to study ion channel function in primary cells and murine pain models. -
Dawn Duane
Clinical Professor, Pediatric Neurology
Clinical Professor (By courtesy), PediatricsCurrent Research and Scholarly InterestsI am a general pediatric neurologist. My interest is in clinical diagnosis and treatment of common neurologic diseases in pediatric patients and teaching feature doctors, neurologists and pediatric neurologists about pediatric neurology.
-
Anne Dubin
Endowed Professor of Pediatric Cardiology
Current Research and Scholarly InterestsArrhythmia management in pediatric heart failure, especially resynchronization therapy in congenital heart disease,Radio frequency catheter ablation of pediatric arrhythmias,
-
Laramie Duncan
Assistant Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
Current Research and Scholarly InterestsOur work is at the intersection of statistical genetics, psychiatry, and neuroscience. We use massive datasets and primarily computational approaches to identify mechanisms contributing to mental health problems like schizophrenia and depression. The overall goal of the lab is to discover fundamental information about psychiatric disorders, and ultimately to build more effective approaches to classification, prevention, and treatment.
-
Alexander Dunn
Professor of Chemical Engineering
Current Research and Scholarly InterestsMy lab is deeply interested in uncovering the physical principles that underlie the construction of complex, multicellular animal life.
-
James Dunn
Professor of Surgery (Pediatric Surgery)
Current Research and Scholarly InterestsIntestinal lengthening for short bowel syndrome
Intestinal stem cell therapy for intestinal failure
Skin derived precursor cell therapy for enteric neuromuscular dysfunction
Intestinal tissue engineering -
Ram Duriseti
Clinical Associate Professor, Emergency Medicine
BioRam's Doctoral background and academic interests are in the computational modeling of complex decisions, algorithm design and implementation, and data driven decision making. Outside of clinical work, his main competencies in this regard are software development, algorithm design and implementation, cost-effectiveness analysis, and decision analysis through computational models. He has also collaborated with industry to create and deploy operation specific software involving statistical computing and reasoning under inference. He has been practicing clinical Emergency Medicine in both community and academic settings for over 20 years.
https://www.shiftgen.com/about
https://www.linkedin.com/in/ram-duriseti-991614/ -
Gozde Durmus
Assistant Professor (Research) of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsDr. Durmus' research focuses on applying micro/nano-technologies to investigate cellular heterogeneity for single-cell analysis and personalized medicine. At Stanford, she is developing platform technologies for sorting and monitoring cells at the single-cell resolution. This magnetic levitation-based technology is used for wide range of applications in medicine, such as, label-free detection of circulating tumor cells (CTCs) from blood; high-throughput drug screening; and rapid detection and monitoring of antibiotic resistance in real-time. During her PhD, she has engineered nanoparticles and nanostructured surfaces to decrease antibiotic-resistant infections.
-
John Eaton
Charles Lee Powell Foundation Professor in the School of Engineering, Emeritus
BioEaton uses experiments and computational simulations to study the flow and heat transfer in complex turbulent flows, especially those relevant to turbomachinery, particle-laden flows, and separated flows, and to develop new techniques for precise control of gas and surface temperature during manufacturing processes.
-
Noelle Hanako Ebel
Clinical Associate Professor, Pediatrics - Gastroenterology
Current Research and Scholarly InterestsCurrent projects include:
-indications for combined heart-liver transplantation
-mitigating perioperative bleeding during cardiac surgery in children with Alagille syndrome
-congenital heart disease and liver transplantation
-subspecialty advocacy -
Elizabeth Egan
Associate Professor of Pediatrics (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsMalaria is a parasitic disease transmitted by mosquitos that is a leading cause of childhood mortality globally. Public health efforts to control malaria have historically been hampered by the rapid development of drug resistance. The goal of our research is to understand the molecular determinants of critical host-pathogen interactions in malaria, with a focus on the erythrocyte host cell. Our long-term goal is to develop novel approaches to prevent or treat malaria and improve child health.
-
Shirit Einav
Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsOur basic research program focuses on understanding the roles of virus-host interactions in viral infection and disease pathogenesis. This program is combined with translational efforts to apply this knowledge for the development of broad-spectrum host-centered antiviral approaches to combat emerging viral infections, including dengue, encephalitic alphaviruses, coronaviruses, and filoviruses, and means to predict disease progression.
-
Ifeanyichukwu Emmanuel Eke
Postdoctoral Scholar, Pathology
BioI am a chemical biologist with a broad interest in defining the mechanisms-of-action of novel compounds that can be used as potential drugs or diagnostic probes for different bacterial and viral infections. In addition to my flair for research, I am passionate about teaching, mentorship, leadership, and entrepreneurship.
-
Yasser El-Sayed, Professor
Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery
Current Research and Scholarly InterestsHigh Risk Obstetrics: preterm labor, preeclampsia, medical and surgical complications of pregnancy, prenatal diagnosis and therapy
-
Cameron Ellis
Assistant Professor of Psychology
BioDr. Cameron Ellis is an Assistant Professor in the Department of Psychology. He leads the Scaffolding of Cognition Team, which focuses on the question: What is it like to be an infant? His team uses methods from neuroscience and cognitive science to assess the basic building blocks of the developing mind and answer this question. They are particularly interested in questions about how infants perceive, attend, learn, and remember. One prominent approach they use is fMRI with awake behaving infants. This provides unprecedented ways to access the cognitive mechanisms underlying the infant mind.
Dr. Ellis received his Ph.D. from Yale University in 2021. Before that, he received a Masters from Princeton University (2017) and a Bachelor of Science from Auckland University, New Zealand (2013). He was awarded the FLUX Dissertation Prize (2021) and the James Grossman Dissertation Prize (2021), as well as the William Kessen Teaching Award (2019). -
Edgar Engleman
Professor of Pathology and of Medicine (Immunology and Rheumatology)
On Leave from 07/01/2025 To 06/30/2026Current Research and Scholarly InterestsDendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.
-
Jesse Engreitz
Assistant Professor of Genetics
Current Research and Scholarly InterestsRegulatory elements in the human genome harbor thousands of genetic risk variants for common diseases and could reveal targets for therapeutics — if only we could map the complex regulatory wiring that connects 2 million regulatory elements with 21,000 genes in thousands of cell types in the human body.
We combine experimental and computational genomics, biochemistry, molecular biology, and genetics to assemble regulatory maps of the human genome and uncover biological mechanisms of disease. -
Daniel Bruce Ennis
Professor of Radiology (Veterans Affairs) and, by courtesy, of Bioengineering
Current Research and Scholarly InterestsThe Cardiac MRI Group seeks to invent and validate methods to quantify cardiac performance. We develop methods to measure cardiac structure (DWI/DTI), function (tagging and DENSE), flow (PC-MRI), and remodeling (diffusion, T1-mapping, fat-water mapping) for pediatrics and adults.
Fundamental to our research is a set of tools for numerically optimizing gradient waveforms, Bloch simulations, and patient-specific 3D-printed cardiovascular structures connected to computer controlled flow pumps. -
Gregory Enns
Professor of Pediatrics (Genetics)
Current Research and Scholarly Interestsmitochondrial genomics, lysosomal disorders, tandem-mass spectrometry newborn screening, and inborn errors of metabolism presentations and natural history
-
Mo Esfahanian, MD, D. ABA, FAAP
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsMy current interests include investigating the role of regional anesthesia to enhance postoperative recovery in pediatrics, including the suprazygomatic maxillary nerve block for cleft palate surgery, and the external oblique intercostal plane block for first stage microtia repair.
-
Neir Eshel, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)
BioDr. Eshel (he/him/his) is a tenure-track Assistant Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine.
His clinical focus is the full-spectrum mental health care of sexual and gender minorities, with particular interest in depression, anxiety, and the complex effects of trauma in this population. He works in collaboration with other primary care and mental health providers at the Stanford LGBTQ+ program.
His research interests (www.staarlab.com) include the use of optogenetic, electrophysiological, neuroimaging, and behavioral approaches to probe the neural circuits of reward processing, decision making, and social behavior. He has won multi-year grants from the National Institutes of Health, Burroughs-Wellcome Fund, One Mind Foundation, Sergey Brin Family Foundation, Brain and Behavior Research Foundation, and Simons Foundation to further his research.
Dr. Eshel has published articles on the behavioral roles for dopamine, serotonin, and acetylcholine; the neuroscience of irritability, depression, and addiction; LGBTQ health; and the mechanism of transcranial magnetic stimulation. His work has appeared in Nature, Science, Neuron, Nature Neuroscience, Annual Review of Neuroscience, JAMA, JAMA Psychiatry, Neuropsychopharmacology, Proceedings of the National Academy of Sciences, and the Journal of Neuroscience, among other leading journals. He is a co-inventor on a patent for a new class of drugs for addiction, and also the author of the book Learning: The Science Inside, a publication of the American Association for the Advancement of Science.
He has delivered presentations on the neural circuits of motivated behavior, anger expression in patients with PTSD, how dopamine facilitates learning, and LGBTQ-related topics at keynotes and invited seminars in >10 countries. He is also an associate editor of the Journal of Gay and Lesbian Mental Health, and an ad-hoc reviewer for numerous publications including Nature, Science, Neuron, Nature Communications, JAMA Psychiatry, Biological Psychiatry, and Current Biology.
Dr. Eshel has won honors for his scholarship and advocacy, including the Marshall Scholarship, the One Mind Rising Star Award, the Outstanding Resident Award from the National Institute of Mental Health, the Science and SciLifeLab Grand Prize for Young Scientists, the Freedman Award (honorable mention) from the Brain and Behavior Research Foundation, the Polymath Award from Stanford's psychiatry department, and the National LGBT Health Achievement Award.
He is a member of the American Psychiatric Association, American College of Neuropsychopharmacology, Society of Biological Psychiatry, Association of Gay & Lesbian Psychiatrists, Society for Neuroscience, and other professional associations. He is also an advocate for LGBTQ rights, recently serving as the chair of Stanford's LGBTQ+ Benefits Advocacy Committee.
Prior to Stanford, Dr. Eshel trained and conducted research at the National Institutes of Health, Princeton University, the World Health Organization, University College London, and Harvard University. -
Carlos O. Esquivel, M.D., Ph.D.,FACS
Arnold and Barbara Silverman Professor in Pediatric Transplantation and Professor of Surgery (Abdominal Transplantation) and of Pediatrics (Gastroenterology, Hepatology and Nutrition)
Current Research and Scholarly Interests1) Induction of immunotolerance
2) Rejection of liver and intestinal transplantation.
3) Clinical outcomes of children with unresectable liver tumors.
